| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear receptor activity | 2.05e-07 | 60 | 44 | 5 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 2.23e-07 | 61 | 44 | 5 | GO:0098531 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF12 ZNF808 ZNF880 NR2F6 ZNF492 IKZF3 ZNF486 PPARA PPARD PPARG ZNF473 ZNF789 NR2F2 TET1 | 2.42e-07 | 1244 | 44 | 14 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF12 ZNF808 ZNF880 NR2F6 ZNF492 IKZF3 ZNF486 PPARA PPARD PPARG ZNF473 ZNF789 NR2F2 TET1 | 3.15e-07 | 1271 | 44 | 14 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF12 ZNF808 ZNF880 NR2F6 ZNF492 IKZF3 ZNF486 PPARA PPARD PPARG ZNF473 ZNF789 NR2F2 TET1 | 1.66e-06 | 1459 | 44 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 5.48e-06 | 16 | 44 | 3 | GO:0004697 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF12 ZNF808 ZNF880 NR2F6 ZNF492 IKZF3 ZNF486 PPARA PPARD PPARG ZNF473 ZNF789 NR2F2 | 6.84e-06 | 1412 | 44 | 13 | GO:0000981 |
| GeneOntologyMolecularFunction | zinc ion binding | RNF144B ADAM30 RASGRP1 NEIL3 NR2F6 PPARA PPARD PPARG NR2F2 TET1 | 1.85e-05 | 891 | 44 | 10 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | RNF144B ADAM30 RASGRP1 NEIL3 NR2F6 PPARA PPARD PPARG NR2F2 TET1 | 2.08e-04 | 1189 | 44 | 10 | GO:0046914 |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.29e-04 | 54 | 44 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 2.58e-04 | 11 | 44 | 2 | GO:0004955 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 3.09e-04 | 12 | 44 | 2 | GO:0004954 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 3.64e-04 | 13 | 44 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 5.58e-04 | 16 | 44 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 5.58e-04 | 16 | 44 | 2 | GO:0004953 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 9.70e-04 | 21 | 44 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 1.38e-03 | 25 | 44 | 2 | GO:0003707 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.69e-03 | 107 | 44 | 3 | GO:0033293 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 1.73e-03 | 28 | 44 | 2 | GO:0036041 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 2.34e-03 | 120 | 44 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 2.85e-03 | 36 | 44 | 2 | GO:0031624 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.62e-03 | 140 | 44 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 3.68e-03 | 41 | 44 | 2 | GO:0000217 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 3.86e-03 | 42 | 44 | 2 | GO:0044390 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 4.23e-03 | 44 | 44 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 5.31e-03 | 320 | 44 | 4 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 5.66e-03 | 326 | 44 | 4 | GO:0001217 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 7.51e-03 | 560 | 44 | 5 | GO:0001228 | |
| GeneOntologyBiologicalProcess | negative regulation of cholesterol storage | 1.97e-06 | 12 | 44 | 3 | GO:0010887 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol storage | 1.01e-05 | 20 | 44 | 3 | GO:0010885 | |
| GeneOntologyBiologicalProcess | positive regulation of fatty acid oxidation | 1.36e-05 | 22 | 44 | 3 | GO:0046321 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid storage | 2.28e-05 | 26 | 44 | 3 | GO:0010888 | |
| GeneOntologyBiologicalProcess | cholesterol storage | 2.28e-05 | 26 | 44 | 3 | GO:0010878 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA transcription | 3.90e-05 | 31 | 44 | 3 | GO:1902894 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA metabolic process | 5.17e-05 | 34 | 44 | 3 | GO:2000629 | |
| GeneOntologyBiologicalProcess | regulation of lipid transporter activity | 6.64e-05 | 6 | 44 | 2 | GO:0110112 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of triglyceride | 6.64e-05 | 6 | 44 | 2 | GO:0010891 | |
| GeneOntologyBiologicalProcess | response to wounding | 6.67e-05 | 659 | 44 | 8 | GO:0009611 | |
| GeneOntologyBiologicalProcess | wound healing | 7.61e-05 | 493 | 44 | 7 | GO:0042060 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 9.16e-05 | 215 | 44 | 5 | GO:1905952 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 9.81e-05 | 42 | 44 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 1.23e-04 | 927 | 44 | 9 | GO:0030155 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF12 NR2F6 PPARA PPARD PPARG ZNF473 ZNF827 SETD5 NR2F2 SMYD2 TET1 | 1.28e-04 | 1399 | 44 | 11 | GO:0045892 |
| GeneOntologyBiologicalProcess | regulation of fatty acid oxidation | 1.29e-04 | 46 | 44 | 3 | GO:0046320 | |
| GeneOntologyBiologicalProcess | fatty acid oxidation | 1.32e-04 | 122 | 44 | 4 | GO:0019395 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF12 NR2F6 PPARA PPARD PPARG ZNF473 ZNF827 SETD5 NR2F2 SMYD2 TET1 | 1.40e-04 | 1413 | 44 | 11 | GO:1902679 |
| GeneOntologyBiologicalProcess | lipid oxidation | 1.63e-04 | 129 | 44 | 4 | GO:0034440 | |
| GeneOntologyBiologicalProcess | positive regulation of fatty acid metabolic process | 1.76e-04 | 51 | 44 | 3 | GO:0045923 | |
| GeneOntologyBiologicalProcess | fatty acid transport | 1.78e-04 | 132 | 44 | 4 | GO:0015908 | |
| GeneOntologyBiologicalProcess | membrane protein ectodomain proteolysis | 1.97e-04 | 53 | 44 | 3 | GO:0006509 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle cell migration | 1.97e-04 | 53 | 44 | 3 | GO:0014912 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.97e-04 | 53 | 44 | 3 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of metallopeptidase activity | 1.98e-04 | 10 | 44 | 2 | GO:1905049 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 2.12e-04 | 138 | 44 | 4 | GO:0030512 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 2.40e-04 | 416 | 44 | 6 | GO:0030522 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to insulin stimulus | 2.71e-04 | 59 | 44 | 3 | GO:1900077 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 2.93e-04 | 276 | 44 | 5 | GO:0007179 | |
| GeneOntologyBiologicalProcess | regulation of lipid storage | 2.99e-04 | 61 | 44 | 3 | GO:0010883 | |
| GeneOntologyBiologicalProcess | membrane protein proteolysis | 3.45e-04 | 64 | 44 | 3 | GO:0033619 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.77e-04 | 66 | 44 | 3 | GO:0010543 | |
| GeneOntologyBiologicalProcess | cytokine production | 4.16e-04 | 1091 | 44 | 9 | GO:0001816 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid metabolic process | 4.18e-04 | 165 | 44 | 4 | GO:0045834 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage derived foam cell differentiation | 4.59e-04 | 15 | 44 | 2 | GO:0010745 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of triglyceride | 4.59e-04 | 15 | 44 | 2 | GO:0010889 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | PRKD2 ZNF808 IKZF3 PPARA PPARD PPARG ZNF473 ZNF827 NR2F2 TET1 | 5.61e-04 | 1390 | 44 | 10 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of lipid transport | 5.68e-04 | 179 | 44 | 4 | GO:0032368 | |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 5.68e-04 | 319 | 44 | 5 | GO:0051222 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid localization | 6.16e-04 | 78 | 44 | 3 | GO:1905953 | |
| GeneOntologyBiologicalProcess | fatty acid beta-oxidation | 6.64e-04 | 80 | 44 | 3 | GO:0006635 | |
| GeneOntologyBiologicalProcess | sequestering of triglyceride | 6.66e-04 | 18 | 44 | 2 | GO:0030730 | |
| GeneOntologyBiologicalProcess | lipid transport | 6.77e-04 | 506 | 44 | 6 | GO:0006869 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 7.18e-04 | 336 | 44 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 7.38e-04 | 192 | 44 | 4 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 7.39e-04 | 83 | 44 | 3 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 7.65e-04 | 84 | 44 | 3 | GO:0061614 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 7.68e-04 | 194 | 44 | 4 | GO:0050714 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 7.73e-04 | 519 | 44 | 6 | GO:0001558 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 7.82e-04 | 195 | 44 | 4 | GO:1903844 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 7.88e-04 | 343 | 44 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 8.63e-04 | 350 | 44 | 5 | GO:0050708 | |
| GeneOntologyBiologicalProcess | regulation of metallopeptidase activity | 9.10e-04 | 21 | 44 | 2 | GO:1905048 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle cell proliferation | 9.35e-04 | 90 | 44 | 3 | GO:0048662 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 1.09e-03 | 213 | 44 | 4 | GO:0015718 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 1.09e-03 | 95 | 44 | 3 | GO:0070527 | |
| GeneOntologyBiologicalProcess | negative regulation of collagen biosynthetic process | 1.09e-03 | 23 | 44 | 2 | GO:0032966 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.09e-03 | 23 | 44 | 2 | GO:0090331 | |
| GeneOntologyBiologicalProcess | lipid modification | 1.11e-03 | 214 | 44 | 4 | GO:0030258 | |
| GeneOntologyBiologicalProcess | regulation of protein transport | 1.15e-03 | 560 | 44 | 6 | GO:0051223 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.18e-03 | 218 | 44 | 4 | GO:0090101 | |
| GeneOntologyBiologicalProcess | regulation of growth | 1.19e-03 | 777 | 44 | 7 | GO:0040008 | |
| GeneOntologyBiologicalProcess | lipid localization | 1.20e-03 | 565 | 44 | 6 | GO:0010876 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 1.27e-03 | 382 | 44 | 5 | GO:0016042 | |
| GeneOntologyBiologicalProcess | enamel mineralization | 1.29e-03 | 25 | 44 | 2 | GO:0070166 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to insulin stimulus | 1.30e-03 | 101 | 44 | 3 | GO:1900076 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid transport | 1.34e-03 | 102 | 44 | 3 | GO:0032370 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.37e-03 | 580 | 44 | 6 | GO:0022407 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 1.38e-03 | 103 | 44 | 3 | GO:2000628 | |
| GeneOntologyBiologicalProcess | inflammatory response | 1.45e-03 | 1043 | 44 | 8 | GO:0006954 | |
| GeneOntologyBiologicalProcess | lipid storage | 1.46e-03 | 105 | 44 | 3 | GO:0019915 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 1.51e-03 | 27 | 44 | 2 | GO:0010875 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.54e-03 | 1053 | 44 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | 1.58e-03 | 1316 | 44 | 9 | GO:0032101 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 1.61e-03 | 403 | 44 | 5 | GO:1904951 | |
| GeneOntologyBiologicalProcess | negative regulation of collagen metabolic process | 1.62e-03 | 28 | 44 | 2 | GO:0010713 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 1.62e-03 | 28 | 44 | 2 | GO:0042953 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.62e-03 | 28 | 44 | 2 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response | 1.66e-03 | 239 | 44 | 4 | GO:0050728 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 1.74e-03 | 410 | 44 | 5 | GO:0046942 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 1.74e-03 | 29 | 44 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | negative regulation of protein serine/threonine kinase activity | 1.76e-03 | 112 | 44 | 3 | GO:0071901 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.78e-03 | 412 | 44 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | organic acid transport | 1.78e-03 | 412 | 44 | 5 | GO:0015849 | |
| GeneOntologyBiologicalProcess | negative regulation of cell migration | 1.91e-03 | 419 | 44 | 5 | GO:0030336 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 1.94e-03 | 116 | 44 | 3 | GO:0009062 | |
| GeneOntologyBiologicalProcess | cell activation | 1.95e-03 | 1356 | 44 | 9 | GO:0001775 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.99e-03 | 31 | 44 | 2 | GO:0010544 | |
| GeneOntologyBiologicalProcess | cell growth | 2.00e-03 | 625 | 44 | 6 | GO:0016049 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 2.09e-03 | 119 | 44 | 3 | GO:0010586 | |
| GeneOntologyBiologicalProcess | amelogenesis | 2.12e-03 | 32 | 44 | 2 | GO:0097186 | |
| HumanPheno | Increased proportion autoreactive unresponsive CD21-/low B cells | 6.01e-06 | 2 | 13 | 2 | HP:0033207 | |
| MousePheno | abnormal IgG level | 4.31e-06 | 392 | 35 | 8 | MP:0020174 | |
| MousePheno | abnormal immunoglobulin level | 3.05e-05 | 513 | 35 | 8 | MP:0002490 | |
| MousePheno | abnormal humoral immune response | 5.99e-05 | 564 | 35 | 8 | MP:0001800 | |
| MousePheno | overexpanded pulmonary alveolus | 1.05e-04 | 37 | 35 | 3 | MP:0001183 | |
| MousePheno | abnormal B cell physiology | 1.11e-04 | 616 | 35 | 8 | MP:0002459 | |
| MousePheno | decreased immunoglobulin level | 1.17e-04 | 315 | 35 | 6 | MP:0002460 | |
| MousePheno | increased circulating cholesterol level | 1.26e-04 | 463 | 35 | 7 | MP:0005178 | |
| MousePheno | abnormal IgG1 level | 1.31e-04 | 200 | 35 | 5 | MP:0020175 | |
| MousePheno | increased cholesterol level | 2.07e-04 | 502 | 35 | 7 | MP:0003982 | |
| MousePheno | increased sterol level | 2.15e-04 | 505 | 35 | 7 | MP:0012226 | |
| MousePheno | abnormal IgM level | 2.17e-04 | 223 | 35 | 5 | MP:0020180 | |
| MousePheno | abnormal liver lobule morphology | 2.46e-04 | 229 | 35 | 5 | MP:0008987 | |
| MousePheno | abnormal liver parenchyma morphology | 3.23e-04 | 243 | 35 | 5 | MP:0008986 | |
| MousePheno | decreased IgG level | 3.42e-04 | 246 | 35 | 5 | MP:0001805 | |
| Domain | 1Cnucl_rcpt | 1.06e-08 | 3 | 42 | 3 | IPR003074 | |
| Domain | zf-C4 | 5.76e-08 | 46 | 42 | 5 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 5.76e-08 | 46 | 42 | 5 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 5.76e-08 | 46 | 42 | 5 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 5.76e-08 | 46 | 42 | 5 | IPR001723 | |
| Domain | ZnF_C4 | 5.76e-08 | 46 | 42 | 5 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 5.76e-08 | 46 | 42 | 5 | PS51030 | |
| Domain | - | 6.43e-08 | 47 | 42 | 5 | 1.10.565.10 | |
| Domain | HOLI | 7.17e-08 | 48 | 42 | 5 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 7.17e-08 | 48 | 42 | 5 | IPR000536 | |
| Domain | Hormone_recep | 7.17e-08 | 48 | 42 | 5 | PF00104 | |
| Domain | DAG/PE-bd | 1.29e-07 | 21 | 42 | 4 | IPR020454 | |
| Domain | - | 1.73e-07 | 57 | 42 | 5 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 1.89e-07 | 58 | 42 | 5 | IPR013088 | |
| Domain | zf-C2H2_6 | 4.19e-07 | 314 | 42 | 8 | PF13912 | |
| Domain | - | ZNF12 ZNF808 ZNF880 ZNF492 IKZF3 ZNF486 ZNF473 ZNF789 ZNF532 ZNF827 | 1.94e-06 | 679 | 42 | 10 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF12 ZNF808 ZNF880 ZNF492 IKZF3 ZNF486 ZNF473 ZNF789 ZNF532 ZNF827 | 2.36e-06 | 694 | 42 | 10 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF12 ZNF808 ZNF880 ZNF492 IKZF3 ZNF486 ZNF473 ZNF789 ZNF532 ZNF827 | 6.28e-06 | 775 | 42 | 10 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF12 ZNF808 ZNF880 ZNF492 IKZF3 ZNF486 ZNF473 ZNF789 ZNF532 ZNF827 | 6.43e-06 | 777 | 42 | 10 | PS00028 |
| Domain | Znf_C2H2-like | ZNF12 ZNF808 ZNF880 ZNF492 IKZF3 ZNF486 ZNF473 ZNF789 ZNF532 ZNF827 | 7.95e-06 | 796 | 42 | 10 | IPR015880 |
| Domain | C1_1 | 8.00e-06 | 57 | 42 | 4 | PF00130 | |
| Domain | Znf_C2H2 | ZNF12 ZNF808 ZNF880 ZNF492 IKZF3 ZNF486 ZNF473 ZNF789 ZNF532 ZNF827 | 8.77e-06 | 805 | 42 | 10 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF12 ZNF808 ZNF880 ZNF492 IKZF3 ZNF486 ZNF473 ZNF789 ZNF532 ZNF827 | 9.07e-06 | 808 | 42 | 10 | SM00355 |
| Domain | ZF_DAG_PE_1 | 1.27e-05 | 64 | 42 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.27e-05 | 64 | 42 | 4 | PS50081 | |
| Domain | C1 | 1.35e-05 | 65 | 42 | 4 | SM00109 | |
| Domain | KRAB | 1.36e-05 | 358 | 42 | 7 | PS50805 | |
| Domain | KRAB | 1.36e-05 | 358 | 42 | 7 | PF01352 | |
| Domain | PE/DAG-bd | 1.44e-05 | 66 | 42 | 4 | IPR002219 | |
| Domain | KRAB | 1.65e-05 | 369 | 42 | 7 | SM00349 | |
| Domain | KRAB | 1.68e-05 | 370 | 42 | 7 | IPR001909 | |
| Domain | zf-C2H2 | ZNF12 ZNF808 ZNF880 ZNF492 IKZF3 ZNF486 ZNF473 ZNF789 ZNF827 | 1.88e-05 | 693 | 42 | 9 | PF00096 |
| Domain | EGF_1 | 2.12e-05 | 255 | 42 | 6 | PS00022 | |
| Domain | EGF-like_CS | 2.42e-05 | 261 | 42 | 6 | IPR013032 | |
| Domain | EGF_2 | 2.63e-05 | 265 | 42 | 6 | PS01186 | |
| Domain | Prot_kin_PKC_delta | 2.95e-05 | 4 | 42 | 2 | IPR014376 | |
| Domain | COUP_TF | 4.92e-05 | 5 | 42 | 2 | IPR003068 | |
| Domain | Peptidase_M12B_N | 9.13e-05 | 39 | 42 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 9.13e-05 | 39 | 42 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 9.86e-05 | 40 | 42 | 3 | PS00427 | |
| Domain | ADAM_MEPRO | 9.86e-05 | 40 | 42 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 9.86e-05 | 40 | 42 | 3 | PS50214 | |
| Domain | Reprolysin | 9.86e-05 | 40 | 42 | 3 | PF01421 | |
| Domain | Peptidase_M12B | 9.86e-05 | 40 | 42 | 3 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 1.06e-04 | 41 | 42 | 3 | PS00546 | |
| Domain | Disintegrin_dom | 1.06e-04 | 41 | 42 | 3 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 1.23e-04 | 43 | 42 | 3 | IPR001818 | |
| Domain | EGF_3 | 1.76e-04 | 235 | 42 | 5 | PS50026 | |
| Domain | EGF-like_dom | 2.30e-04 | 249 | 42 | 5 | IPR000742 | |
| Domain | EGF_extracell | 3.31e-04 | 60 | 42 | 3 | IPR013111 | |
| Domain | EGF_2 | 3.31e-04 | 60 | 42 | 3 | PF07974 | |
| Domain | Disintegrin_CS | 5.81e-04 | 16 | 42 | 2 | IPR018358 | |
| Domain | ADAM_CR | 7.38e-04 | 18 | 42 | 2 | PF08516 | |
| Domain | MetalloPept_cat_dom | 7.99e-04 | 81 | 42 | 3 | IPR024079 | |
| Domain | - | 7.99e-04 | 81 | 42 | 3 | 3.40.390.10 | |
| Domain | - | 9.14e-04 | 20 | 42 | 2 | 4.10.70.10 | |
| Domain | DISIN | 1.01e-03 | 21 | 42 | 2 | SM00050 | |
| Domain | Disintegrin | 1.01e-03 | 21 | 42 | 2 | PF00200 | |
| Domain | zf-MYND | 1.01e-03 | 21 | 42 | 2 | PF01753 | |
| Domain | EPHD | 1.11e-03 | 22 | 42 | 2 | PS51805 | |
| Domain | Znf_MYND | 1.11e-03 | 22 | 42 | 2 | IPR002893 | |
| Domain | ZF_MYND_1 | 1.11e-03 | 22 | 42 | 2 | PS01360 | |
| Domain | ZF_MYND_2 | 1.11e-03 | 22 | 42 | 2 | PS50865 | |
| Domain | ZINC_PROTEASE | 1.39e-03 | 98 | 42 | 3 | PS00142 | |
| Domain | ADAM_Cys-rich | 1.67e-03 | 27 | 42 | 2 | IPR006586 | |
| Domain | ACR | 1.67e-03 | 27 | 42 | 2 | SM00608 | |
| Domain | EGF_CA | 2.59e-03 | 122 | 42 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.71e-03 | 124 | 42 | 3 | IPR001881 | |
| Domain | EGF | 2.84e-03 | 126 | 42 | 3 | PF00008 | |
| Domain | Pkinase_C | 3.13e-03 | 37 | 42 | 2 | IPR017892 | |
| Domain | LDLR_class-A_CS | 3.65e-03 | 40 | 42 | 2 | IPR023415 | |
| Domain | SET | 3.83e-03 | 41 | 42 | 2 | PF00856 | |
| Domain | Pkinase_C | 4.02e-03 | 42 | 42 | 2 | PF00433 | |
| Domain | Ldl_recept_a | 4.60e-03 | 45 | 42 | 2 | PF00057 | |
| Domain | SET | 4.80e-03 | 46 | 42 | 2 | SM00317 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 5.10e-08 | 38 | 38 | 5 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 5.10e-08 | 38 | 38 | 5 | MM15865 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.20e-05 | 53 | 38 | 4 | M8276 | |
| Pathway | WP_PPAR_SIGNALING | 3.05e-05 | 67 | 38 | 4 | M39553 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 3.42e-05 | 69 | 38 | 4 | M13088 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 4.28e-05 | 73 | 38 | 4 | MM15995 | |
| Pathway | PID_RXR_VDR_PATHWAY | 4.50e-05 | 26 | 38 | 3 | M162 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 5.05e-05 | 27 | 38 | 3 | M12123 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 6.98e-05 | 30 | 38 | 3 | MM15866 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 9.32e-05 | 33 | 38 | 3 | MM1448 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 1.02e-04 | 34 | 38 | 3 | M16393 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 1.11e-04 | 35 | 38 | 3 | M39488 | |
| Pathway | WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS | 1.96e-04 | 8 | 38 | 2 | M45529 | |
| Pathway | WP_GASTRIN_SIGNALING | 2.50e-04 | 115 | 38 | 4 | M39866 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 2.52e-04 | 9 | 38 | 2 | M39819 | |
| Pathway | WP_ENERGY_METABOLISM | 2.87e-04 | 48 | 38 | 3 | M39590 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.87e-04 | 48 | 38 | 3 | MM14987 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.07e-03 | 75 | 38 | 3 | M39568 | |
| Pathway | WP_GALANIN_RECEPTOR_PATHWAY | 1.44e-03 | 21 | 38 | 2 | M40039 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.48e-03 | 84 | 38 | 3 | M1008 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 1.50e-03 | 185 | 38 | 4 | M39718 | |
| Pathway | REACTOME_SUMOYLATION | 1.62e-03 | 189 | 38 | 4 | M27214 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.04e-03 | 25 | 38 | 2 | MM14511 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 27512842 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 9113987 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 29346772 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 25758678 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 26332656 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 15917308 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 26098621 | ||
| Pubmed | Roles of PPARs on regulating myocardial energy and lipid homeostasis. | 1.89e-09 | 3 | 44 | 3 | 17356846 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 27860527 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 23262340 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 28292576 | ||
| Pubmed | Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors. | 1.89e-09 | 3 | 44 | 3 | 15811118 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 22944052 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 15128052 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 23811234 | ||
| Pubmed | Effects of PPARs/20-HETE on the renal impairment under diabetic conditions. | 1.89e-09 | 3 | 44 | 3 | 31163124 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 8240342 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 21487230 | ||
| Pubmed | Genetic manipulations of PPARs: effects on obesity and metabolic disease. | 1.89e-09 | 3 | 44 | 3 | 17389768 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 15578089 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 30607709 | ||
| Pubmed | PPAR nuclear receptors and altered RPE lipid metabolism in age-related macular degeneration. | 1.89e-09 | 3 | 44 | 3 | 20238044 | |
| Pubmed | Peroxisome proliferator-activated receptors, orphans with ligands and functions. | 1.89e-09 | 3 | 44 | 3 | 9211064 | |
| Pubmed | Selective intranuclear redistribution of PPAR isoforms by RXR alpha. | 1.89e-09 | 3 | 44 | 3 | 11923467 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 26673968 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 19948841 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 19157507 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 9918810 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 8041794 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 20045185 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 18388689 | ||
| Pubmed | [Association of regulatory genes polymorphisms with aerobic and anaerobic performance of athletes]. | 7.55e-09 | 4 | 44 | 3 | 17926914 | |
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 18037994 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 8910358 | ||
| Pubmed | Protein kinase Cδ mediates the activation of protein kinase D2 in platelets. | 7.55e-09 | 4 | 44 | 3 | 21736870 | |
| Pubmed | Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. | 7.55e-09 | 4 | 44 | 3 | 18354499 | |
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 19279199 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 19681917 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 11980898 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 34081964 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 21967852 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 18182682 | ||
| Pubmed | Peroxisome proliferator-activated receptor delta regulates mitofusin 2 expression in the heart. | 1.89e-08 | 5 | 44 | 3 | 19265701 | |
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 9933587 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 15615782 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 19208777 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 15730864 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 12962497 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 17436029 | ||
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 16751185 | ||
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 32589900 | ||
| Pubmed | CRY1/2 Selectively Repress PPARδ and Limit Exercise Capacity. | 3.77e-08 | 6 | 44 | 3 | 28683290 | |
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 15722453 | ||
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 11089532 | ||
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 22205725 | ||
| Pubmed | Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. | 3.77e-08 | 6 | 44 | 3 | 20448152 | |
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 24879443 | ||
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 17272748 | ||
| Pubmed | Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. | 6.59e-08 | 7 | 44 | 3 | 12970571 | |
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 11903058 | ||
| Pubmed | 1.05e-07 | 8 | 44 | 3 | 11514592 | ||
| Pubmed | Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs. | 1.05e-07 | 8 | 44 | 3 | 28122051 | |
| Pubmed | Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. | 1.05e-07 | 8 | 44 | 3 | 10385625 | |
| Pubmed | Gadd45 family proteins are coactivators of nuclear hormone receptors. | 1.58e-07 | 9 | 44 | 3 | 10872826 | |
| Pubmed | 1.58e-07 | 9 | 44 | 3 | 15888456 | ||
| Pubmed | 2.25e-07 | 10 | 44 | 3 | 7588749 | ||
| Pubmed | PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice. | 6.81e-07 | 14 | 44 | 3 | 23093780 | |
| Pubmed | 6.81e-07 | 14 | 44 | 3 | 23995233 | ||
| Pubmed | 1.05e-06 | 16 | 44 | 3 | 22090424 | ||
| Pubmed | 1.05e-06 | 16 | 44 | 3 | 22154759 | ||
| Pubmed | 1.27e-06 | 17 | 44 | 3 | 28291835 | ||
| Pubmed | Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene. | 1.56e-06 | 2 | 44 | 2 | 24486511 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 15731109 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 17451173 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22685582 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 23374874 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 20653996 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 14677574 | ||
| Pubmed | Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases. | 1.56e-06 | 2 | 44 | 2 | 24107399 | |
| Pubmed | The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis. | 1.56e-06 | 2 | 44 | 2 | 32198386 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 12594814 | ||
| Pubmed | Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice. | 1.56e-06 | 2 | 44 | 2 | 24244369 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 17548619 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 23700465 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22940187 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 33075048 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 27476612 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 20081051 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 12059785 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 15935279 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 38387308 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 19141539 | ||
| Pubmed | Molecular mechanism of PPAR in the regulation of age-related inflammation. | 1.56e-06 | 2 | 44 | 2 | 18313368 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 23545576 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22021335 | ||
| Pubmed | PPAR(alpha) and PPAR(gamma) activators suppress the monocyte-macrophage apoB-48 receptor. | 1.56e-06 | 2 | 44 | 2 | 12700342 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 19422369 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 23166318 | ||
| Pubmed | The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders. | 1.56e-06 | 2 | 44 | 2 | 34638914 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 20645257 | ||
| Interaction | TNP1 interactions | 2.11e-06 | 12 | 44 | 3 | int:TNP1 | |
| Interaction | RXRG interactions | 3.29e-06 | 47 | 44 | 4 | int:RXRG | |
| Interaction | RXRA interactions | 3.26e-05 | 169 | 44 | 5 | int:RXRA | |
| Interaction | GADD45B interactions | 6.05e-05 | 35 | 44 | 3 | int:GADD45B | |
| Interaction | HSP90AA1 interactions | LRP1 PRKD2 PRKCD NEIL3 PRKCQ IKZF3 PPARA PPARD PPARG USP19 SMYD2 | 6.30e-05 | 1263 | 44 | 11 | int:HSP90AA1 |
| GeneFamily | Nuclear hormone receptors | 5.56e-08 | 49 | 38 | 5 | 71 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF12 ZNF808 ZNF880 ZNF492 IKZF3 ZNF486 ZNF473 ZNF789 ZNF532 ZNF827 | 1.58e-06 | 718 | 38 | 10 | 28 |
| GeneFamily | C2 domain containing protein kinases | 1.92e-04 | 10 | 38 | 2 | 835 | |
| GeneFamily | Low density lipoprotein receptors | 3.31e-04 | 13 | 38 | 2 | 634 | |
| GeneFamily | Zinc fingers MYND-type | 8.81e-04 | 21 | 38 | 2 | 87 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.46e-03 | 27 | 38 | 2 | 47 | |
| GeneFamily | PHD finger proteins | 1.53e-02 | 90 | 38 | 2 | 88 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 4.65e-07 | 175 | 44 | 6 | M7625 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 8.47e-06 | 289 | 44 | 6 | M2196 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 1.26e-05 | 180 | 44 | 5 | M6878 | |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP | 1.77e-05 | 193 | 44 | 5 | M4961 | |
| Coexpression | GSE10325_BCELL_VS_MYELOID_UP | 1.95e-05 | 197 | 44 | 5 | M3081 | |
| Coexpression | GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN | 2.00e-05 | 198 | 44 | 5 | M7139 | |
| Coexpression | GSE11057_PBMC_VS_MEM_CD4_TCELL_DN | 2.00e-05 | 198 | 44 | 5 | M3121 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN | 2.10e-05 | 200 | 44 | 5 | M9597 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 2.10e-05 | 200 | 44 | 5 | M6237 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_CLASSICAL | 1.54e-04 | 161 | 44 | 4 | M2121 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | 2.25e-04 | 746 | 44 | 7 | M40863 | |
| Coexpression | GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN | 2.51e-04 | 183 | 44 | 4 | M7627 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 2.56e-04 | 184 | 44 | 4 | M19988 | |
| Coexpression | GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP | 2.62e-04 | 185 | 44 | 4 | M5643 | |
| Coexpression | IL2_UP.V1_UP | 2.89e-04 | 190 | 44 | 4 | M2822 | |
| Coexpression | GSE29618_BCELL_VS_MDC_UP | 3.13e-04 | 194 | 44 | 4 | M4943 | |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP | 3.19e-04 | 195 | 44 | 4 | M3089 | |
| Coexpression | GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN | 3.32e-04 | 197 | 44 | 4 | M3344 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 3.32e-04 | 197 | 44 | 4 | M8980 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 3.32e-04 | 197 | 44 | 4 | M7543 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN | 3.32e-04 | 197 | 44 | 4 | M6219 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 3.39e-04 | 198 | 44 | 4 | M8969 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | 3.39e-04 | 198 | 44 | 4 | M6230 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP | 3.45e-04 | 199 | 44 | 4 | M9414 | |
| Coexpression | GSE3039_NKT_CELL_VS_B1_BCELL_UP | 3.45e-04 | 199 | 44 | 4 | M6432 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP | 3.45e-04 | 199 | 44 | 4 | M8390 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP | 3.45e-04 | 199 | 44 | 4 | M9077 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 3.45e-04 | 199 | 44 | 4 | M9238 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_DC_UP | 3.45e-04 | 199 | 44 | 4 | M4475 | |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP | 3.45e-04 | 199 | 44 | 4 | M3087 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP | 3.52e-04 | 200 | 44 | 4 | M8026 | |
| Coexpression | GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP | 3.52e-04 | 200 | 44 | 4 | M8073 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN | 3.52e-04 | 200 | 44 | 4 | M7595 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | 3.52e-04 | 200 | 44 | 4 | M8972 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 3.52e-04 | 200 | 44 | 4 | M8967 | |
| Coexpression | GSE360_DC_VS_MAC_L_DONOVANI_UP | 3.52e-04 | 200 | 44 | 4 | M5174 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN | 3.52e-04 | 200 | 44 | 4 | M9533 | |
| Coexpression | GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP | 3.52e-04 | 200 | 44 | 4 | M2933 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN | 3.52e-04 | 200 | 44 | 4 | M9588 | |
| Coexpression | GSE42021_TREG_VS_TCONV_PLN_UP | 3.52e-04 | 200 | 44 | 4 | M9572 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN | 3.52e-04 | 200 | 44 | 4 | M9570 | |
| Coexpression | GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP | 3.52e-04 | 200 | 44 | 4 | M4115 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP | 3.52e-04 | 200 | 44 | 4 | M6234 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.52e-04 | 200 | 44 | 4 | M9188 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 4.05e-04 | 822 | 44 | 7 | M6782 | |
| Coexpression | SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN | 5.67e-04 | 21 | 44 | 2 | M41206 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 5.67e-04 | 21 | 44 | 2 | M4767 | |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_1_DN | 6.77e-04 | 238 | 44 | 4 | M18841 | |
| Coexpression | NABA_ECM_REGULATORS | 6.77e-04 | 238 | 44 | 4 | M3468 | |
| Coexpression | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP | 6.81e-04 | 23 | 44 | 2 | M1184 | |
| Coexpression | SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP | 6.81e-04 | 23 | 44 | 2 | M41207 | |
| Coexpression | NABA_ECM_REGULATORS | 7.20e-04 | 242 | 44 | 4 | MM17062 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 3.90e-07 | 336 | 44 | 8 | GSM538413_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24-.Th, 4- 8+ TCRhi 24-/lo, Thymus, avg-3 | 5.43e-07 | 351 | 44 | 8 | GSM399379_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 4.62e-06 | 328 | 44 | 7 | GSM605756_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | 5.73e-06 | 339 | 44 | 7 | GSM399382_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.MLN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3 | 7.89e-06 | 356 | 44 | 7 | GSM538409_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | 1.25e-05 | 382 | 44 | 7 | GSM476684_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 1.33e-05 | 386 | 44 | 7 | GSM605787_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 1.38e-05 | 388 | 44 | 7 | GSM605790_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Sp, TCRd+ CD3e+, Spleen, avg-3 | 1.50e-05 | 393 | 44 | 7 | GSM476672_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3 | 1.82e-05 | 405 | 44 | 7 | GSM605796_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4int8+.Th, 4int 8+ TCRhi, Thymus, avg-3 | 2.76e-05 | 289 | 44 | 6 | GSM399367_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.LN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3 | 6.18e-05 | 334 | 44 | 6 | GSM538406_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8.Sp.B16, 4- 8+ TCR+ 45+, B16 Melanoma Spleen, avg-3 | 6.28e-05 | 335 | 44 | 6 | GSM605770_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP69+.Th, 4- 8+ TCRhi 69+, Thymus, avg-3 | 9.62e-05 | 362 | 44 | 6 | GSM399385_500 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 9.70e-05 | 224 | 44 | 5 | GSM403994_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.81e-04 | 256 | 44 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | alpha beta T cells, T.4+8int.Th, 4+ 8int TCRhi, Thymus, avg-3 | 2.13e-04 | 56 | 44 | 3 | GSM399362_100 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | 2.22e-04 | 422 | 44 | 6 | GSM399442_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#4_top-relative-expression-ranked_200 | 3.62e-04 | 67 | 44 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_200_k4 | |
| CoexpressionAtlas | alpha beta T cells, T.4+8int.Th, 4+ 8int TCRhi, Thymus, avg-3 | 3.88e-04 | 302 | 44 | 5 | GSM399362_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3 | 3.94e-04 | 303 | 44 | 5 | GSM538398_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DP69+.Th, 4+ 8+ TCRlo/int 69+, Thymus, avg-3 | 4.06e-04 | 305 | 44 | 5 | GSM399394_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 4.68e-04 | 175 | 44 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 4.84e-04 | 317 | 44 | 5 | GSM538412_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 5.57e-04 | 327 | 44 | 5 | GSM538380_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.LN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 6.30e-04 | 336 | 44 | 5 | GSM538374_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 6.30e-04 | 336 | 44 | 5 | GSM605758_500 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 6.47e-04 | 338 | 44 | 5 | GSM403987_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#2_top-relative-expression-ranked_500 | 6.56e-04 | 82 | 44 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k2 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.Sp, 4+ 8- 25- 62Lhi 44lo, Spleen, avg-4 | 6.56e-04 | 339 | 44 | 5 | GSM538382_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem.Sp, 4+ 8- 25- 44hi 122lo, Spleen, avg-3 | 6.92e-04 | 343 | 44 | 5 | GSM538365_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.MLN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 7.01e-04 | 344 | 44 | 5 | GSM538377_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3+25+.Sp, 4+ 8- GFP+ 25+, Spleen, avg-3 | 7.01e-04 | 344 | 44 | 5 | GSM399365_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.30e-04 | 197 | 44 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#4_top-relative-expression-ranked_500 | 7.53e-04 | 86 | 44 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k4 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 7.79e-04 | 87 | 44 | 3 | GSM476655_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 7.97e-04 | 354 | 44 | 5 | GSM605753_500 | |
| CoexpressionAtlas | CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1 | 8.28e-04 | 357 | 44 | 5 | GSM403986_500 | |
| CoexpressionAtlas | CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3 | 8.38e-04 | 358 | 44 | 5 | GSM605909_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem44h62l.Sp, CD4 TCRb CD44hi CD62Llo, Spleen, avg-3 | 8.49e-04 | 359 | 44 | 5 | GSM538371_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th.TCRbko, TCRd+ Vg1.1+, Thymus, avg-3 | 8.81e-04 | 362 | 44 | 5 | GSM605784_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24-.Th, 4+ 8- TCRhi 24-/lo, Thymus, avg-3 | 9.14e-04 | 365 | 44 | 5 | GSM399370_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3 | 9.14e-04 | 365 | 44 | 5 | GSM399376_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 9.17e-04 | 92 | 44 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 9.26e-04 | 210 | 44 | 4 | GSM403995_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#5_top-relative-expression-ranked_100 | 9.44e-04 | 22 | 44 | 2 | gudmap_developingLowerUrinaryTract_P1_ureter_100_k5 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | 1.01e-03 | 373 | 44 | 5 | GSM605781_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.act.Sp, TCRd+ Vg2- CD44+, Spleen, avg-3 | 1.06e-03 | 377 | 44 | 5 | GSM476681_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.10e-03 | 220 | 44 | 4 | gudmap_kidney_adult_RenMedVasc_Tie2_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.18e-03 | 799 | 44 | 7 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.act.Sp, TCRd+ Vg2+ CD44+, Spleen, avg-3 | 1.30e-03 | 395 | 44 | 5 | GSM476678_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | 1.34e-03 | 398 | 44 | 5 | GSM538338_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.act.IEL, CD8a+ CD8b- TCRd+ Vg5- CD44hi, Small Intestine, avg-3 | 1.40e-03 | 402 | 44 | 5 | GSM605808_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.47e-03 | 406 | 44 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2A.Th, Lin-/lo CD25hi CD44+ cKithi, Thymus, avg-2 | 1.51e-03 | 409 | 44 | 5 | GSM791139_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.53e-03 | 28 | 44 | 2 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k2 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3A.Th, Lin-/lo CD25hi CD44- CD28-, Thymus, avg-3 | 1.63e-03 | 416 | 44 | 5 | GSM791146_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_500 | 1.65e-03 | 417 | 44 | 5 | gudmap_kidney_adult_RenMedVasc_Tie2_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | 1.69e-03 | 850 | 44 | 7 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.73e-03 | 249 | 44 | 4 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 1.74e-03 | 422 | 44 | 5 | GSM476658_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 1.76e-03 | 423 | 44 | 5 | GSM476655_500 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.80e-07 | 169 | 44 | 5 | b059304543876f514d5c7214f1f0a2da00f10a67 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.80e-07 | 169 | 44 | 5 | 945f737984c4de70a4e9c214053b005358053dd5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.00e-07 | 170 | 44 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-07 | 170 | 44 | 5 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-07 | 170 | 44 | 5 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | CTRL-Lymphoid|CTRL / Disease state, Lineage and Cell class | 1.03e-06 | 184 | 44 | 5 | 26fb2c4e6cb9950c27eb15428e7e74e5abb4397d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-06 | 191 | 44 | 5 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | Severe-Lymphoid-T-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 1.41e-06 | 196 | 44 | 5 | 29d4db6816fead2ad9136ef824e0775463b02159 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-06 | 197 | 44 | 5 | 0b4fdf0131dd67a86ee3209fa66db0ca2e01a10e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-06 | 197 | 44 | 5 | 927bf36bad3bcb7346c13b660777c1c0de7dc322 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-06 | 197 | 44 | 5 | b3876076684781fb8384117f2cf367d828985986 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-06 | 197 | 44 | 5 | 3e09158507df08c08e08613ce23617206280c911 | |
| ToppCell | Severe_COVID-19-T/NK-CD4+_T_2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.48e-06 | 198 | 44 | 5 | c8c9343c19198b6534f8f07e74405e29b3a164bf | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-06 | 198 | 44 | 5 | a5f5c0b42ae43ba48a7e4f06c4ad179b2244d941 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.48e-06 | 198 | 44 | 5 | 93773b1abbf46b39e320d628077bf94958b872a4 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_CTL|World / disease group, cell group and cell class (v2) | 1.48e-06 | 198 | 44 | 5 | 03c01fc384d46eec55ff730edbab8a3fde618ed8 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.48e-06 | 198 | 44 | 5 | 812ffe7369bf83ae5071970934c8831611db9557 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-06 | 198 | 44 | 5 | bb99db3e04d547248ea66953c2f8dd55c530461c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.85e-06 | 124 | 44 | 4 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 152 | 44 | 4 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 153 | 44 | 4 | 6dcab3d50ab50051955204dc4e4a64c1ca855bcd | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 153 | 44 | 4 | f6ef14d949107c08cb3690e26ec91e194cb43518 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 156 | 44 | 4 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 156 | 44 | 4 | bb64bf520cb74897a01c64924a85a1550df2b801 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 157 | 44 | 4 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 160 | 44 | 4 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 160 | 44 | 4 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 161 | 44 | 4 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 161 | 44 | 4 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 161 | 44 | 4 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | BAL-Severe-cDC_2|Severe / Compartment, Disease Groups and Clusters | 2.16e-05 | 166 | 44 | 4 | 602a72a607534d5f21eddd2c7a52a57084f4920f | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 167 | 44 | 4 | 2ee1660be117e20f24557522345572d11cbee813 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 168 | 44 | 4 | d823979335ac6b5d1f062ebb741c759d2f919dbf | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 168 | 44 | 4 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 168 | 44 | 4 | c0aef5947b1d7e2c81a7481c509feda1687fcd7f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 168 | 44 | 4 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 168 | 44 | 4 | c861f80aa12caf54a94d93e38539ff41dc5227a6 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 168 | 44 | 4 | f377ff4c066a9857ad14d245e56325ad220e22e1 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 169 | 44 | 4 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 169 | 44 | 4 | 411556e93adcbb7e4d79b02f3dc72963ec8a0759 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 169 | 44 | 4 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 169 | 44 | 4 | 39b1acfd099abb9de18c29c05c7a67709ea76775 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-05 | 171 | 44 | 4 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 171 | 44 | 4 | d322cc042a6f4b4aa8ef80ae977edbce9e266d48 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-05 | 171 | 44 | 4 | 00739085fdbc4d64c9faacba2c2adeab580dd2b1 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 172 | 44 | 4 | 51bea97564a33f0060c546c9be4bf8bf8f1660f6 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-05 | 172 | 44 | 4 | 5f58ff6cac32546d07b2a49ed250b6c7aa417188 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 172 | 44 | 4 | be4dd4ba8d7a651677c797c25fd75f14e627415a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 173 | 44 | 4 | 7a3115e7cf7e2f345192cde0656a7f0193594a5f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 175 | 44 | 4 | c8cfe0ac0c1ac447c626a623cc49692a0b177a1c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 175 | 44 | 4 | 61fbd8f685d3daad46449e4c0386a38886496566 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.78e-05 | 177 | 44 | 4 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 2.78e-05 | 177 | 44 | 4 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-05 | 177 | 44 | 4 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.78e-05 | 177 | 44 | 4 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | CTRL-Lymphoid-T_cell_&_NK_cell|CTRL / Disease state, Lineage and Cell class | 2.78e-05 | 177 | 44 | 4 | e73d8e78a96b63e27a8a7694c62b3c44ec7ecfe6 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 178 | 44 | 4 | 6c1b5087581ca8cea976d89ea6f34088c8fc3668 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.97e-05 | 180 | 44 | 4 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 182 | 44 | 4 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|CF / Disease state, Lineage and Cell class | 3.10e-05 | 182 | 44 | 4 | a8dfc59a3974e3433f434676b7c2749d0fcfc8b2 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.17e-05 | 183 | 44 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.17e-05 | 183 | 44 | 4 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.17e-05 | 183 | 44 | 4 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-05 | 184 | 44 | 4 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 184 | 44 | 4 | 8fc047977fad38fcd26eebcc279a688efd342ed8 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-05 | 184 | 44 | 4 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-05 | 185 | 44 | 4 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 185 | 44 | 4 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.37e-05 | 186 | 44 | 4 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 3.37e-05 | 186 | 44 | 4 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.37e-05 | 186 | 44 | 4 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.37e-05 | 186 | 44 | 4 | 701eea0016d69f0f9d29b613948f91239096e6c7 | |
| ToppCell | mild_COVID-19-CD4+_CTL|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.44e-05 | 187 | 44 | 4 | 49196d07e4716c87d33229a4569bdb6b4613b3eb | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 3.44e-05 | 187 | 44 | 4 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 187 | 44 | 4 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-05 | 188 | 44 | 4 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-05 | 188 | 44 | 4 | 31129152386e9aba16f749d78da12a08b916e6f8 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.59e-05 | 189 | 44 | 4 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | NS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.59e-05 | 189 | 44 | 4 | fb7572fb4c7c43886d57a025decad076f32a14c4 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.67e-05 | 190 | 44 | 4 | 55df73c8b696967a925b1772631f6900eff0fa30 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 3.67e-05 | 190 | 44 | 4 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | NS-critical-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.67e-05 | 190 | 44 | 4 | 84f9f5ac29ff0f929a589b76efa61d4c570e76b0 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 3.67e-05 | 190 | 44 | 4 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.67e-05 | 190 | 44 | 4 | 494fbab37305a7f92cddec75b291d42282555f5f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 190 | 44 | 4 | 07ea0578ca0561077557203ae660530f53fc4067 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.67e-05 | 190 | 44 | 4 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 190 | 44 | 4 | 5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f | |
| ToppCell | facs-Trachea-nan-3m-Lymphocytic|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 191 | 44 | 4 | 89eb4e30052d0d4a2952157ca743291900ce8de2 | |
| ToppCell | facs-Trachea-nan-3m-Lymphocytic-T_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 191 | 44 | 4 | 0bf575eba311745fb75f9523f7fc81f73848e25d | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.74e-05 | 191 | 44 | 4 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.74e-05 | 191 | 44 | 4 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 3.74e-05 | 191 | 44 | 4 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-05 | 191 | 44 | 4 | b9ef6d82b86271b7e0875a399bb9aae84ef5bad3 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.74e-05 | 191 | 44 | 4 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | facs-Trachea-nan-3m-Lymphocytic-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 191 | 44 | 4 | c57df363e3a6e61d2bdca1955330f1899b964267 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.74e-05 | 191 | 44 | 4 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 3.74e-05 | 191 | 44 | 4 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-Treg|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.82e-05 | 192 | 44 | 4 | cd34defac6565d34db507918e791b09c79f7d1f8 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 3.82e-05 | 192 | 44 | 4 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 3.82e-05 | 192 | 44 | 4 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| Drug | indeglitazar | 6.73e-09 | 3 | 44 | 3 | CID011395145 | |
| Drug | 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid | 6.73e-09 | 3 | 44 | 3 | DB07724 | |
| Drug | Bezafibrate | 6.73e-09 | 3 | 44 | 3 | DB01393 | |
| Drug | 2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid | 6.73e-09 | 3 | 44 | 3 | ctd:C487401 | |
| Drug | norathyriol | 8.87e-09 | 37 | 44 | 5 | CID005281656 | |
| Drug | AC1LDMDX | 1.94e-08 | 43 | 44 | 5 | CID000621355 | |
| Drug | AC1MHGE4 | 2.69e-08 | 4 | 44 | 3 | CID003025998 | |
| Drug | dihydrosterculic acid | 3.64e-08 | 18 | 44 | 4 | CID000160788 | |
| Drug | octadecenedioic acid | 6.72e-08 | 5 | 44 | 3 | CID006440435 | |
| Drug | Dioctyl Sulfosuccinic Acid | 6.72e-08 | 5 | 44 | 3 | ctd:D004143 | |
| Drug | 2-ethylhexanoic acid | 6.72e-08 | 5 | 44 | 3 | ctd:C040668 | |
| Drug | Heptanoic Acids | 6.72e-08 | 5 | 44 | 3 | ctd:D006538 | |
| Drug | AC1L9JWY | 6.72e-08 | 5 | 44 | 3 | CID000446639 | |
| Drug | ETYA | 1.25e-07 | 122 | 44 | 6 | CID000001780 | |
| Drug | norathyriol | 1.34e-07 | 6 | 44 | 3 | ctd:C069053 | |
| Drug | 8-hydroxyeicosatetraenoic acid | 1.34e-07 | 6 | 44 | 3 | ctd:C047628 | |
| Drug | ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate | 1.34e-07 | 6 | 44 | 3 | ctd:C504648 | |
| Drug | GW2433 | 1.34e-07 | 6 | 44 | 3 | CID000001517 | |
| Drug | mangrove | 2.27e-07 | 468 | 44 | 9 | CID000000965 | |
| Drug | LY 518674 | 2.34e-07 | 7 | 44 | 3 | ctd:C479889 | |
| Drug | 9,11-octadecadienoic acid | 3.07e-07 | 142 | 44 | 6 | CID000074607 | |
| Drug | benzoxazinone analogue | 3.75e-07 | 8 | 44 | 3 | CID000468715 | |
| Drug | PPAPs | 3.75e-07 | 8 | 44 | 3 | CID009576869 | |
| Drug | T0901317 | 4.90e-07 | 81 | 44 | 5 | CID000447912 | |
| Drug | 1 Em | 5.53e-07 | 83 | 44 | 5 | CID000446621 | |
| Drug | monoisononylphthalate | 5.61e-07 | 9 | 44 | 3 | ctd:C471400 | |
| Drug | 9,12,15-octadecatrienoic acid | 7.98e-07 | 167 | 44 | 6 | CID000000860 | |
| Drug | AC1NUP8U | 8.00e-07 | 10 | 44 | 3 | CID005487216 | |
| Drug | 15(S)-HETrE | 8.00e-07 | 10 | 44 | 3 | CID000001437 | |
| Drug | mono-benzyl phthalate | 8.00e-07 | 10 | 44 | 3 | ctd:C103325 | |
| Drug | Musk T | 1.10e-06 | 11 | 44 | 3 | CID000061014 | |
| Drug | 17-[2-hydroxy-6-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-3-[(2S,3R,4S,5S)-5-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4,4,8,14-tetramethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde | 1.10e-06 | 11 | 44 | 3 | CID011968562 | |
| Drug | GW501516 | 1.46e-06 | 12 | 44 | 3 | CID009803963 | |
| Drug | Ertiprotafib | 1.46e-06 | 12 | 44 | 3 | CID000157049 | |
| Drug | tetradecylselenoacetic acid | 1.46e-06 | 12 | 44 | 3 | ctd:C410666 | |
| Drug | NSC46155 | 1.46e-06 | 12 | 44 | 3 | CID000457869 | |
| Drug | 20-HETE | 1.87e-06 | 106 | 44 | 5 | CID005283157 | |
| Drug | GW2331 | 1.90e-06 | 13 | 44 | 3 | CID000657048 | |
| Drug | 2-bromopalmitate | 1.90e-06 | 13 | 44 | 3 | ctd:C022776 | |
| Drug | E-guggulsterone | 2.05e-06 | 108 | 44 | 5 | CID006439929 | |
| Drug | pitavastatin | 2.68e-06 | 114 | 44 | 5 | CID005282451 | |
| Drug | dansyl-DAG | 3.01e-06 | 15 | 44 | 3 | CID000129493 | |
| Drug | RK-1409B | 3.01e-06 | 15 | 44 | 3 | CID003036125 | |
| Drug | fibrates | 3.17e-06 | 118 | 44 | 5 | CID000002797 | |
| Drug | (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid | 3.65e-06 | 2 | 44 | 2 | DB08483 | |
| Drug | MHY966 | 3.65e-06 | 2 | 44 | 2 | ctd:C580737 | |
| Drug | Gw 9544 | 3.65e-06 | 2 | 44 | 2 | CID000446642 | |
| Drug | mono-n-hexyl phthalate | 3.65e-06 | 2 | 44 | 2 | ctd:C049841 | |
| Drug | naveglitazar | 3.65e-06 | 2 | 44 | 2 | ctd:C517861 | |
| Drug | Phenylpropionates | 3.65e-06 | 2 | 44 | 2 | ctd:D010666 | |
| Drug | n-heptyl-beta-d-glucopyranoside | 3.65e-06 | 2 | 44 | 2 | CID000113557 | |
| Drug | mono-n-octyl phthalate | 3.65e-06 | 2 | 44 | 2 | ctd:C041260 | |
| Drug | LY 465608 | 3.65e-06 | 2 | 44 | 2 | ctd:C453901 | |
| Drug | 4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid | 3.71e-06 | 16 | 44 | 3 | ctd:C572961 | |
| Drug | BM 17.0744 | 3.71e-06 | 16 | 44 | 3 | CID009929731 | |
| Drug | anti-oxLDL | 3.71e-06 | 16 | 44 | 3 | CID003083542 | |
| Drug | 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 3.71e-06 | 16 | 44 | 3 | ctd:D019377 | |
| Drug | Fatty Acids | 3.85e-06 | 55 | 44 | 4 | ctd:D005227 | |
| Drug | 17alpha-estradiol | LRP1 PRKD2 PRKCD LRP12 NR2F6 PRKCQ PPARA PPARD PPARG CLCN5 TIMP3 NR2F2 | 4.48e-06 | 1303 | 44 | 12 | CID000000450 |
| Drug | GW0072 | 4.49e-06 | 17 | 44 | 3 | CID000449532 | |
| Drug | AC1NP8CI | 4.49e-06 | 17 | 44 | 3 | CID005153863 | |
| Drug | AC1L1JQC | 4.49e-06 | 17 | 44 | 3 | CID000005157 | |
| Drug | daphnoretin | 4.49e-06 | 17 | 44 | 3 | CID005281406 | |
| Drug | JTT-501 | 4.49e-06 | 17 | 44 | 3 | CID000154000 | |
| Drug | dodecylthioacetic acid | 5.38e-06 | 18 | 44 | 3 | CID000083701 | |
| Drug | TAPP-Br | 6.39e-06 | 19 | 44 | 3 | CID000160326 | |
| Drug | AC1L419E | 6.39e-06 | 19 | 44 | 3 | CID000099951 | |
| Drug | KRP-297 | 7.50e-06 | 20 | 44 | 3 | CID000151183 | |
| Drug | Diglycerides | 7.50e-06 | 20 | 44 | 3 | ctd:D004075 | |
| Drug | 2-ethylhexanoic acid | 8.74e-06 | 21 | 44 | 3 | CID000008697 | |
| Drug | KS-619-1 | 8.74e-06 | 21 | 44 | 3 | CID000128369 | |
| Drug | K-259-2 | 8.74e-06 | 21 | 44 | 3 | CID006438946 | |
| Drug | broussochalcone A | 8.74e-06 | 21 | 44 | 3 | CID006438825 | |
| Drug | ezetimibe | 9.29e-06 | 147 | 44 | 5 | CID000150311 | |
| Drug | ragaglitazar | 1.09e-05 | 3 | 44 | 2 | ctd:C432703 | |
| Drug | 5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide | 1.09e-05 | 3 | 44 | 2 | ctd:C116017 | |
| Drug | N-methylpentanamide | 1.09e-05 | 3 | 44 | 2 | CID000022591 | |
| Drug | didecyl phthalate | 1.09e-05 | 3 | 44 | 2 | ctd:C027718 | |
| Drug | gnetin C | 1.09e-05 | 3 | 44 | 2 | ctd:C575740 | |
| Drug | linoleoyl-coenzyme A | 1.09e-05 | 3 | 44 | 2 | ctd:C026562 | |
| Drug | 2,2-dichloro-12-(p-chlorophenyl)-dodecanoic acid | 1.09e-05 | 3 | 44 | 2 | ctd:C116893 | |
| Drug | oleoyl-coenzyme A | 1.09e-05 | 3 | 44 | 2 | ctd:C017585 | |
| Drug | NSC 29059 | 1.09e-05 | 3 | 44 | 2 | CID000097701 | |
| Drug | stearoyl-coenzyme A | 1.09e-05 | 3 | 44 | 2 | ctd:C017725 | |
| Drug | arachidonic acid trifluoromethyl ketone | 1.13e-05 | 153 | 44 | 5 | CID000002224 | |
| Drug | C-1b | 1.13e-05 | 72 | 44 | 4 | CID006102740 | |
| Drug | perfluorooctane sulfonate | 1.16e-05 | 23 | 44 | 3 | CID000074483 | |
| Drug | rebaudioside A | 1.32e-05 | 24 | 44 | 3 | ctd:C025474 | |
| Drug | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid | 1.50e-05 | 25 | 44 | 3 | ctd:C520164 | |
| Drug | GW0742 | 1.50e-05 | 25 | 44 | 3 | CID009934458 | |
| Drug | GW 7647 | 1.50e-05 | 25 | 44 | 3 | ctd:C453899 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.53e-05 | 163 | 44 | 5 | 7453_DN | |
| Drug | 6,9,12-octadecatrienoic acid | 1.56e-05 | 78 | 44 | 4 | CID000003453 | |
| Drug | disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate | 1.70e-05 | 26 | 44 | 3 | ctd:C076126 | |
| Drug | tesaglitazar | 1.70e-05 | 26 | 44 | 3 | CID000208901 | |
| Drug | stevioside | 1.70e-05 | 26 | 44 | 3 | ctd:C012043 | |
| Drug | 8-HETE | 1.70e-05 | 26 | 44 | 3 | CID000001898 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.72e-05 | 167 | 44 | 5 | 3979_DN | |
| Drug | ethyl tert-butyl ether | 1.91e-05 | 27 | 44 | 3 | ctd:C098546 | |
| Drug | pseudohypericin | 1.91e-05 | 27 | 44 | 3 | CID005281751 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 3.18e-05 | 43 | 42 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | hypertension (implicated_via_orthology) | 3.33e-05 | 128 | 42 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 4.16e-05 | 47 | 42 | 3 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | Autoimmune Lymphoproliferative Syndrome | 5.51e-05 | 8 | 42 | 2 | C1328840 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.29e-04 | 12 | 42 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Non-alcoholic Fatty Liver Disease | 1.37e-04 | 70 | 42 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 1.37e-04 | 70 | 42 | 3 | C3241937 | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 2.05e-04 | 15 | 42 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | type 1 diabetes mellitus | 3.87e-04 | 242 | 42 | 4 | MONDO_0005147 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 4.49e-04 | 22 | 42 | 2 | EFO_0021115 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 4.54e-04 | 105 | 42 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | Streptozotocin Diabetes | 4.93e-04 | 108 | 42 | 3 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 4.93e-04 | 108 | 42 | 3 | C0011853 | |
| Disease | Alloxan Diabetes | 4.93e-04 | 108 | 42 | 3 | C0002152 | |
| Disease | Dyslipidemias | 5.35e-04 | 24 | 42 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 5.35e-04 | 24 | 42 | 2 | C0598784 | |
| Disease | Toxic Encephalitis | 7.84e-04 | 29 | 42 | 2 | C0154659 | |
| Disease | Neurotoxicity Syndromes | 7.84e-04 | 29 | 42 | 2 | C0235032 | |
| Disease | Encephalopathy, Toxic | 7.84e-04 | 29 | 42 | 2 | C0149504 | |
| Disease | Alzheimer's disease (is_implicated_in) | 8.84e-04 | 132 | 42 | 3 | DOID:10652 (is_implicated_in) | |
| Disease | spontaneous coronary artery dissection | 8.96e-04 | 31 | 42 | 2 | EFO_0010820 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.02e-03 | 33 | 42 | 2 | DOID:9452 (biomarker_via_orthology) | |
| Disease | Vertigo | 1.03e-03 | 139 | 42 | 3 | HP_0002321 | |
| Disease | obesity (biomarker_via_orthology) | 1.21e-03 | 147 | 42 | 3 | DOID:9970 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLHCQKECGNYCLNT | 816 | Q63HQ2 | |
| KCGYNHICFEGQCRN | 631 | Q9H013 | |
| IKQGYRCKDCGMNCH | 566 | O95267 | |
| HGVCNHKFYGKQCCK | 1201 | Q8TE60 | |
| NQCQYCRLKKCFRVG | 106 | P10588 | |
| HHRNQCQYCRLKKCL | 126 | P24468 | |
| QKCFKNCYGENHQRL | 311 | Q9Y5A7 | |
| CKNCKHTFCWYCLQN | 211 | Q7Z419 | |
| QGYQCRQCNAAIHKK | 186 | Q04759 | |
| KNCFFCQPGNFHCKN | 446 | Q9Y561 | |
| YKVYKRPNCGQCHCR | 246 | Q8TAT5 | |
| GYKCRQCNAAIHKKC | 186 | Q05655 | |
| CQIQSYCAKHLKCSQ | 1221 | Q07954 | |
| KCNVCVHQACYGILK | 221 | Q9NQC1 | |
| YCQCDNFSCVRHKGL | 536 | P18564 | |
| QGLQCKDCKFNCHKR | 291 | Q9BZL6 | |
| RGVCNNRKNCHCMYG | 641 | Q9UKF2 | |
| CGNILCHCFNKYRKN | 291 | P51795 | |
| EKPFKCHLCNYACQR | 171 | Q9UKT9 | |
| KQCLGSNLHCLDGCY | 411 | Q3ZCN5 | |
| NKCQYCRFHKCLSVG | 151 | Q07869 | |
| GYYGKHCRKKCNCAN | 601 | O75095 | |
| NRNKCQYCRFQKCLA | 121 | Q03181 | |
| RQCNYKCGFCFHTAK | 81 | Q8WXG1 | |
| YNIRAKSLLHCFQCC | 136 | O14975 | |
| SRNKCQYCRFQKCLA | 186 | P37231 | |
| CNYKVDCACHKGNRN | 396 | Q9C0A6 | |
| CTYCKNRKNSHQICK | 606 | Q8NFU7 | |
| CNHCTKNLVFYNKCS | 646 | Q9HCE3 | |
| TLNNHKRKGFCYGCC | 186 | Q96HI0 | |
| CYRVGYCNQLCQKTH | 811 | O94966 | |
| YKCNECGKVFNRNAH | 296 | Q6PDB4 | |
| HPAQQNGYKCVACCR | 176 | Q5T0L3 | |
| CDVCGKLFNHKQYLA | 261 | Q8N4W9 | |
| CLKGLLQAYCCHNHA | 526 | Q96SB8 | |
| GCDLKNCNKNYHFFC | 121 | Q9UIL8 | |
| KCHLCPYAAKCRANL | 846 | Q17R98 | |
| CKVHKECYNGLNQCL | 91 | Q9P255 | |
| ECNECGKNFYQKLHL | 326 | P17014 | |
| GRCKQAFYCNVECQK | 66 | Q9NRG4 | |
| ECKLHKRGYNGLNQC | 131 | Q96H40 | |
| NYRYHLGCNCKIKSC | 136 | P35625 | |
| HLQNKPYRCHDCGKC | 251 | Q5FWF6 | |
| LYQCQRCQKAFRCHS | 841 | Q8WTR7 |